|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.412 SEK | -2.49% |
|
-4.98% | -68.93% |
| Feb. 23 | Kancera AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 23 | Kancera AB Signs A License Agreement with the University of Newcastle | CI |
Kancera AB (publ) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was SEK 0.753 million compared to SEK 1.7 million a year ago. Net loss was SEK 52.48 million compared to SEK 45.69 million a year ago.
Basic loss per share from continuing operations was SEK 0.9 compared to SEK 0.82 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -68.93% | 15.61M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
KANCERA AB 
